$KNTK

ISQ Global Fund II GP LLC (Wahba Sadek, Bhandari Gautam) sold $19.0M of KNTK (indirect holdings)

ISQ Global Fund II GP LLC sold 360,337 indirectly-held shares of Kinetik Holdings Inc. (KNTK) at an average of $52.63 ($51.38–$54.09, $18.96M total) across 7 trades over 2026-08-13 to 2026-08-17. Filed jointly with I Squared Capital, LLC (10% owner), ISQ Holdings, LLC (10% owner), Wahba Sadek (10% owner) and Bhandari Gautam (10% owner).

Original reporting
SEC EDGAR · ISQ Global Fund II GP LLC, I Squared Capital, LLC, ISQ Holdings, LLC, Wahba Sadek, Bhandari Gautam
Published Aug 18, 2026, 12:01 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 18, 2026, 12:04 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$KNTK
Neutral
medium confidence
Mentioned
$KNTK
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KNTKNeutralLow
01

Why it matters

The newest disclosed fact is the $18.96M indirect open-market sale by a 10% owner over 2026-08-13 to 2026-08-17, with remaining holdings of 993,792 shares.

02

Market read

This is a moderate-notional insider sale disclosure that may influence short-term sentiment, but it does not provide new operating or financial guidance.

03

What to watch

Because the transaction is indirect and not tied to a 10b5-1 plan, traders may over-interpret intent; the filing lacks stated rationale and does not confirm future selling.

Relevance 7/10Novelty 5/10Timing: filed 2026-08-17, covering sales from 2026-08-13 to 2026-08-17

Background

The article is a SEC Form 4 insider transaction disclosure for Kinetik Holdings (KNTK), reported by ISQ Global Fund II GP LLC and co-owners as a 10% owner.

Company-level read

Ticker impact

$KNTKNeutralMedium confidence
Context

Kinetik Holdings (KNTK) disclosed an indirect open-market sale by a 10% owner totaling about $19.0M across 7 trades in mid-August.

Expected impact

Likely limited, short-lived sentiment impact unless follow-on selling continues or is paired with other negative disclosures.

Evidence & confidence

The filing is a Form 4 insider transaction with no 10b5-1 plan and a sizable notional, but it does not include earnings, guidance, or operational/regulatory developments.

Market effects

No sector-wide signal is provided; this is company-specific ownership activity.

None indicated.

None indicated.

Counterpoint

The sale could be liquidity-driven (taxes, diversification) and may not reflect a bearish view of KNTK fundamentals.

Key entities

  • Kinetik Holdings Inc.

    Subject of the Form 4 insider transaction disclosure (KNTK).

  • ISQ Global Fund II GP LLC

    Reporter of the indirect open-market sale totaling about $19.0M.

  • Wahba Sadek

    Co-reporting 10% owner listed on the joint filing.

  • Bhandari Gautam

    Co-reporting 10% owner listed on the joint filing.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$KNTKMedAI 8/10

Why is Kinetik Holdings stock surging today?

Kinetik Holdings' stock rose 5.2% in after-hours trading after Bloomberg reported the company is exploring strategic alternatives, including a potential sale. The company posted record Q2 2026 results with revenue up 36% YoY and net income more than doubled. Kinetik's management had raised its full-year 2026 guidance. U.S. equities broadly sold off during regular trading hours, with the S&P 500, Dow Jones, and Nasdaq all declining.

Med

Kinetik stock jumps 5% on potential sale exploration report

Kinetik Holdings Inc. (KNT) shares rose 5% in after-hours trading after reports it is exploring strategic options, including a potential sale. The company, backed by Blackstone Inc. (BX), has a market value of $8.9B. No final decision has been made. Kinetik closed regular trading at $54.55, down 0.8% but up 30% over the past year.

$KNTKMed

Kinetik Q2 Earnings Call Highlights

Kinetik (NYSE:KNTK) Q2 earnings call said Waha pricing normalization and faster curtailment return, higher WTI and liquids assumptions, and system operating improvements supported a revised outlook. It raised 2026 capex to about $560M, expects Q3 Adjusted EBITDA $260M-$270M and Q4 $270M-$280M, and lifted 2026 volume growth to mid- to high-single digits.